Diabetes Mellitus: A Risk Factor Affecting Visual Outcome in Branch Retinal Vein Occlusion

Abstract

Purpose

The prognosis of visual acuity (VA) after branch retinal vein occlusion (BRVO) in patients with diabetes mellitus is unknown compared to the VA in non-diabetic patients with BRVO. The aim of this study was to evaluate the visual outcome of BRVO in diabetic and non-diabetic patients.

Methods

A retrospective case-control study of diabetic and non-diabetic patients with BRVO was performed. VA and commonly known risk factors and complications of BRVO were compared in a follow-up period of at least 1 year.

Results

A total of 28 eyes of patients with diabetes and 49 eyes of non-diabetic patients with BRVO were included. One year after BRVO, the VA in the patients with diabetes decreased significantly more than that of the non-diabetic patients. During the second year after BRVO, the VA did not change significantly in either group. BRVO in patients with diabetes occurs at an earlier age. Diabetic patients needed more outpatient visits.

Conclusions

The VA 1 year after BRVO in patients with diabetes is worse compared to the VA in patients without diabetes. The VA stabilizes 1 year after onset in both groups. Diabetic patients tend to need more frequent follow-up in order to treat the sequelae of BRVO.

Keywords

Branch retinal vein occlusion Diabetes mellitus Visual acuity Vascular retinal occlusion

Get full access to this article

View all access options for this article.

References

Orth

D.H.

Patz

. Retinal branch vein occlusion. Surv Ophthalmol 1978; 22: 357–76.

Rath

E.Z.

Frank

R.N.

Shin

D.H.

Kim

. Risk factors for retinal vein occlusions, a case-control study. Ophthalmology 1992; 99: 509–14.

Mitchell

Smith

Chang

. Prevalence and associations of retinal vein occlusion in Australia, the Blue Mountains eye study. Arch Ophthalmol 1996; 114: 1243–7.

Eye Disease Case-control Study Group.

Risk factors for branch retinal vein occlusion.

Am J Ophthalmol 1993; 116: 286–96.

Sperduto

R.D.

Hiller

Chew

Risk factors for hemiretinal vein occlusion: comparison with risk factors for central and branch retinal vein occlusion.

Ophthalmology 1998; 105: 765–71.

Simons

B.D.

Brucker

A.J.

. Branch retinal vein occlusion, axial length and other risk factors. Retina 1997; 17: 191–5.

Johnston

R.L.

Brucker

A.J.

Steinmann

Hoffman

M.E.

Holmes

J.H.

. Risk factors of branch retinal vein occlusion. Arch Ophthalmol 1985; 103: 1831–2.

Appiah

A.P.

Greenidge

K.C.

. Factors associated with retinal-vein occlusion in Hispanics. Ann Ophthalmol 1987; 19: 307–12.

Cahill

Karabatzaki

Meleady

Raised plasma homocysteine as a risk factor for retinal vascular occlusive disease.

Br J Ophthalmol 2000; 84: 154–7.

10.

Dodson

P.M.

Clough

C.G.

Downes

S.M.

Kritzinger

E.E.

. Does type II diabetes predispose to retinal vein occlusion? Eur J Ophthalmol 1993; 3: 109–13.

11.

Funderburk

R.L.

Feinberg

E.B.

. Diabetes as a risk factor for retinal neovascularisation in retinal vein occlusion. Ann Ophthalmol 1989; 21: 65–6.